Advanced Search
CHU Zhu-ling, XIE Min, PAN Yi-ming, ZHU Hai-tao. Effect of NF-κB Antisense Oligodeoxynucleotides on Expression of ICAM-1 and Invasive Ability of Pancreatic Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2007, 34(12): 908-911. DOI: 10.3971/j.issn.1000-8578.495
Citation: CHU Zhu-ling, XIE Min, PAN Yi-ming, ZHU Hai-tao. Effect of NF-κB Antisense Oligodeoxynucleotides on Expression of ICAM-1 and Invasive Ability of Pancreatic Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2007, 34(12): 908-911. DOI: 10.3971/j.issn.1000-8578.495

Effect of NF-κB Antisense Oligodeoxynucleotides on Expression of ICAM-1 and Invasive Ability of Pancreatic Carcinoma Cells

More Information
  • Corresponding author:

    XIE Min

  • Received Date: December 06, 2006
  • Revised Date: March 25, 2007
  • Objective  To investigate the effect of the nuclear factor-kappa B (NF-κB) subunit p65 antisense oligonucleotide (ASODN) on the expression of intercellular adhesion molecule-1 ( ICAM-1) and invasive ability of pancreatic carcinoma cells. Methods  p65 ASODN were designed and const ructed and were transfected into human pancreatic cancer cell line PANC-1. The rate of t ransfection was detected by flow cytometry and fluorescence microscope. RT-PCR was used to detect the expression levels of p65 and ICAM-1 mRNA. MTT assay and invasive tests were used to detect the proliferation and invasive ability of PANC-1 cells. Results  p65 ASODN could be successfully transfected into PANC-1 cells. After transfection, the levels of p65 and ICAM-1 mRNA expression, cell proliferation and the invasive ability of PANC-1 cells were reduced ( P < 0. 01) . Conclusion  Transfection of p65 ASODN could effectively inhibit the expression of p65 mRNA and reduce invasive and metastasis ability of PANC-1 cells. The down-regulation of ICAM-1 may play an important role in the inhibitive effect of p65 ASODN.
  • Related Articles

    [1]WANG Yafei, GENG Tianxiang, CHEN Linlin, LI Zhiguo, LI Shipeng. Effect of miR-524-5p on Epithelial-mesenchymal Transition in Esophageal Cancer Cells by Regulating HEG1 Expression[J]. Cancer Research on Prevention and Treatment, 2023, 50(11): 1059-1065. DOI: 10.3971/j.issn.1000-8578.2023.23.0426
    [2]FU Shenbo, GONG Tuotuo, GUO Junjun. Effect of LncRNA PTENP1 on TGF-β-induced Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2023, 50(9): 847-853. DOI: 10.3971/j.issn.1000-8578.2023.22.1246
    [3]DU Jitao, CAO Jian, ZHAO Wen, WAN Xiangbin, LI Zhi. miR-325-3p Regulates Epithelial-mesenchymal Transition, Invasion and Metastasis of Gastric Cancer via Targeting CLDN1 Gene[J]. Cancer Research on Prevention and Treatment, 2021, 48(7): 686-693. DOI: 10.3971/j.issn.1000-8578.2021.20.1200
    [4]WANG Mengxin, LIANG Zhijie, HUANG Donglin, WAN Yan, JIANG Hongmian, LI Hongmian, CHEN Maojian, WEI Changyuan. RSV Inhibits Epithelial-mesenchymal Transition of MDA-MB-231 Cells by Down-regulating POLD1 Expression[J]. Cancer Research on Prevention and Treatment, 2021, 48(5): 445-450. DOI: 10.3971/j.issn.1000-8578.2021.20.1156
    [5]XU Xiaoyan, WANG Jianjun, FENG Zhikun, MEN Yingli, WANG Hui, YANG Jinhua. Correlation of JMJD3 and Epithelial-mesenchymal Transition-related Protein Expression in Breast Cancer and Clinical Significance[J]. Cancer Research on Prevention and Treatment, 2020, 47(4): 268-272. DOI: 10.3971/j.issn.1000-8578.2020.19.0433
    [6]WANG Zuogang, FENG Yan, YU Liang, ZHAO Ziliang, NI Jianlin, ZOU Junqing, HUANG Yang. Effects of ROR1 on Epithelial-mesenchymal Transition in Lung Cancer A549 Cells[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 458-462. DOI: 10.3971/j.issn.1000-8578.2018.17.1311
    [7]CUI Xiaochuan, DING Junli, WAN Xiaolian, ZHU Jianrong. Nrf2-mediated Multidrug Resistance after Epithelial-mesenchymal Transition in Lung Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 432-435. DOI: 10.3971/j.issn.1000-8578.2015.05.002
    [8]KONG Xianglin, CHENG Xianshuo, YANG Zhibin, LI Yunfeng. Contribution of Epithelial-mesenchymal Transition to Vasculogenic Mimicry[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 405-408. DOI: 10.3971/j.issn.1000-8578.2014.04.027
    [9]Gong Yiping, Qi Chubo, Wang Mingwei, Chen Chuang, Zhao Demian, Xu Juan, Shao Jun, Cheng Hongtao, Xia Heshun. Prognosis of Triple-negative Breast Cancer and Its Relevance to Epithelial-mesenchymal Transitions[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 173-176. DOI: 10.3971/j.issn.1000-8578.2012.02.014
    [10]DENG Qin-fang, ZHOU Cai-cun, SU Chun-xia. Clinicopathologic Features and Epidermal Growth Factor Receptor Mutations Associated with Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 258-262. DOI: 10.3971/j.issn.1000-8578.2752

Catalog

    Article views (2396) PDF downloads (652) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return